Equity to Asset ratio is calculated as total stockholders equity divided by total asset. CLS Holdings USA's Total Stockholders Equity for the quarter that ended in Feb. 2025 was $-11.41 Mil. CLS Holdings USA's Total Assets for the quarter that ended in Feb. 2025 was $6.97 Mil.
Therefore, CLS Holdings USA's Equity to Asset Ratio for the quarter that ended in Feb. 2025 was -1.64.
The historical rank and industry rank for CLS Holdings USA's Equity-to-Asset or its related term are showing as below:
CLSH'
s Equity-to-Asset Range Over the Past 10 Years
Min: -139.87 Med: -1.18 Max: 0.82
Current: -1.64
During the past 12 years, the highest Equity to Asset Ratio of CLS Holdings USA was 0.82. The lowest was -139.87. And the median was -1.18.
CLSH's Equity-to-Asset is ranked worse than 96.1% of 1025
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs CLSH: -1.64
CLS Holdings USA Equity-to-Asset Historical Data
The historical data trend for CLS Holdings USA's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CLS Holdings USA's Equity-to-Asset
For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CLS Holdings USA's Equity-to-Asset Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where CLS Holdings USA's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
CLS Holdings USA's Equity to Asset Ratio for the fiscal year that ended in May. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLS Holdings USA (OTCPK:CLSH) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
CLS Holdings USA Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of CLS Holdings USA's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLSH has been successfully added to your 